https://news.medxy.ai/zh/peripheral-venous-nutrition/Medxy AIzh2026-10-07T07:12:57-07:00外周静脉营养可减轻结直肠手术后炎症并促进营养恢复：一项随机试验的启示 https://news.medxy.ai/ja/post-colorectal-surgery-nutrition/Medxy AIja2026-10-07T07:12:39-07:00結腸直腸手術後の炎症を抑え、栄養回復を高める末梢静脈栄養：ランダム化試験からの知見 https://news.medxy.ai/vi/peripheral-vein-nutrition/Medxy AIvi2026-10-07T07:12:21-07:00Dinh dưỡng tĩnh mạch ngoại vi giúp giảm viêm và cải thiện hồi phục dinh dưỡng sau phẫu thuật đại trực tràng: Góc nhìn từ một thử nghiệm ngẫu nhiên https://news.medxy.ai/peripheral-parenteral-nutrition-reduces-inflammation-and-enhances-nutritional-recovery-after-colorectal-surgery-insights-from-a-randomized-trial/Medxy AIen2026-10-07T07:12:03-07:00Peripheral Parenteral Nutrition Reduces Inflammation and Enhances Nutritional Recovery After Colorectal Surgery: Insights from a Randomized Trial https://news.medxy.ai/zh/ai-driven-3d-liver-modeling/Medxy AIzh2026-10-07T07:11:27-07:00AI驱动的三维肝脏建模：提升术前CT预测肝切除复杂度的能力 https://news.medxy.ai/ja/ai-3d-liver-modeling/Medxy AIja2026-10-07T07:11:12-07:00AIが切り拓く3D肝モデリング：術前CTから肝切除難度を高精度予測 https://news.medxy.ai/vi/3d-liver-ai-model/Medxy AIvi2026-10-07T07:10:49-07:00AI tạo mô hình gan 3D: Dự đoán chính xác độ phức tạp cắt gan từ CT trước mổ https://news.medxy.ai/ai-driven-3d-liver-modeling-enhances-prediction-of-liver-resection-complexity-from-preoperative-ct-scans/Medxy AIen2026-10-07T07:10:31-07:00AI-Driven 3D Liver Modeling Enhances Prediction of Liver Resection Complexity from Preoperative CT Scans https://news.medxy.ai/zh/preoperative-education-opioids/Medxy AIzh2026-10-07T07:09:51-07:00术前患者教育对阿片类药物使用与术后疼痛管理的效果评估：随机试验带来的启示 https://news.medxy.ai/ja/preoperative-education-opioids-2/Medxy AIja2026-10-07T07:09:33-07:00術前患者教育はオピオイド使用と術後疼痛管理に有効か：ランダム化試験から見えた実態 https://news.medxy.ai/vi/preoperative-education-opioid-pain/Medxy AIvi2026-10-07T07:09:13-07:00Giáo dục trước phẫu thuật có thực sự giúp giảm dùng opioid và kiểm soát đau sau mổ? Kết quả từ một thử nghiệm ngẫu nhiên https://news.medxy.ai/evaluating-the-effectiveness-of-preoperative-patient-education-on-opioid-use-and-postoperative-pain-management-insights-from-a-randomized-trial/Medxy AIen2026-10-07T07:08:49-07:00Evaluating the Effectiveness of Preoperative Patient Education on Opioid Use and Postoperative Pain Management: Insights from a Randomized Trial https://news.medxy.ai/zh/hospital-recovery-success/Medxy AIzh2026-10-07T07:08:06-07:00破解实施成功密码：医院情境如何塑造加速康复项目的落地 https://news.medxy.ai/ja/hospital-recovery-success-2/Medxy AIja2026-10-07T07:07:51-07:00病院の文脈が成否を分ける：Enhanced Recovery Programs導入を成功に導く要因とは https://news.medxy.ai/vi/hospital-rehabilitation-success/Medxy AIvi2026-10-07T07:07:32-07:00Giải mã thành công: Bối cảnh bệnh viện định hình triển khai Chương trình Phục hồi tăng cường như thế nào https://news.medxy.ai/decoding-success-how-hospital-contexts-shape-enhanced-recovery-program-implementation/Medxy AIen2026-10-07T07:07:13-07:00Decoding Success: How Hospital Contexts Shape Enhanced Recovery Program Implementation https://news.medxy.ai/zh/glp-1-pregnancy/Medxy AIzh2026-10-07T07:06:38-07:00妊娠期GLP-1受体激动剂：围受孕期暴露与围产结局的评估 https://news.medxy.ai/ja/glp-1-pregnancy-2/Medxy AIja2026-10-07T07:06:17-07:00妊娠中のGLP-1受容体作動薬：受胎前後の曝露と周産期転帰をどう評価するか https://news.medxy.ai/vi/glp-1-receptor-agonists-pregnancy/Medxy AIvi2026-10-07T07:05:54-07:00Chất chủ vận thụ thể GLP-1 trong thai kỳ: Đánh giá phơi nhiễm quanh thụ thai và kết cục chu sinh https://news.medxy.ai/glucagon-like-peptide-1-receptor-agonists-in-pregnancy-evaluating-periconception-exposure-and-perinatal-outcomes/Medxy AIen2026-10-07T07:05:33-07:00Glucagon-Like Peptide-1 Receptor Agonists in Pregnancy: Evaluating Periconception Exposure and Perinatal Outcomes https://news.medxy.ai/zh/preeclampsia-bp-monitoring/Medxy AIzh2026-10-07T07:04:49-07:00先兆子痫高风险孕妇远程血压监测优于门诊随访：一项多中心随机对照试验 https://news.medxy.ai/ja/81588-2/Medxy AIja2026-10-07T07:04:31-07:00子癇前症ハイリスク妊婦における遠隔血圧モニタリングは外来での経過観察より優れている：多施設共同無作為化比較試験 https://news.medxy.ai/vi/remote-bp-monitoring/Medxy AIvi2026-10-07T07:04:12-07:00Theo dõi huyết áp từ xa hay khám tại phòng khám: thử nghiệm ngẫu nhiên đa trung tâm ở thai phụ nguy cơ cao tiền sản giật https://news.medxy.ai/remote-blood-pressure-monitoring-versus-office-visits-in-high-risk-preeclampsia-a-multicenter-rct/Medxy AIen2026-10-07T07:03:51-07:00Remote Blood Pressure Monitoring Versus Office Visits in High-Risk Preeclampsia: A Multicenter RCT https://news.medxy.ai/uterus-preserving-focal-excision-in-placenta-percreta-navigating-neovascularization-challenges-based-on-pathoanatomy/Medxy AIen2026-10-07T07:02:07-07:00Uterus-Preserving Focal Excision in Placenta Percreta: Navigating Neovascularization Challenges Based on Pathoanatomy https://news.medxy.ai/exploring-ultrasound-guided-high-intensity-focused-ultrasound-for-safe-placental-vessel-occlusion-in-early-onset-twin-twin-transfusion-syndrome/Medxy AIen2026-10-07T07:00:29-07:00Exploring Ultrasound-Guided High-Intensity Focused Ultrasound for Safe Placental Vessel Occlusion in Early-Onset Twin-Twin Transfusion Syndrome https://news.medxy.ai/zh/catheter-ablation-value/Medxy AIzh2026-10-07T06:59:39-07:00既往卒中房颤患者早期导管消融的价值：基于目标试验模拟的研究启示 https://news.medxy.ai/ja/early-ablation-afib-stroke/Medxy AIja2026-10-07T06:59:21-07:00脳卒中既往を有する心房細動患者に対する早期カテーテルアブレーションの評価：ターゲット試験エミュレーションからの知見 https://news.medxy.ai/vi/early-catheter-ablation/Medxy AIvi2026-10-07T06:58:58-07:00Đánh giá triệt đốt catheter sớm ở bệnh nhân rung nhĩ có tiền sử đột quỵ: phát hiện từ mô phỏng thử nghiệm mục tiêu https://news.medxy.ai/assessing-early-catheter-ablation-in-atrial-fibrillation-patients-with-prior-stroke-insights-from-a-target-trial-emulation/Medxy AIen2026-10-07T06:58:36-07:00Assessing Early Catheter Ablation in Atrial Fibrillation Patients With Prior Stroke: Insights From a Target Trial Emulation https://news.medxy.ai/zh/81569-2/Medxy AIzh2026-10-07T06:57:49-07:00与血浆p-tau217与阿尔茨海默病生物标志物不一致相关的临床因素 https://news.medxy.ai/ja/ptau217-alzheimers-mismatch/Medxy AIja2026-10-07T06:57:27-07:00血漿p-tau217とアルツハイマー病バイオマーカーの不一致に関わる臨床因子：診断と管理への示唆 https://news.medxy.ai/vi/ptau217-alzheimers-diagnosis/Medxy AIvi2026-10-07T06:57:02-07:00Các yếu tố lâm sàng liên quan đến sự không đồng nhất giữa p-tau217 huyết tương và các dấu ấn sinh học bệnh Alzheimer đã thiết lập: Hàm ý cho chẩn đoán và quản lý https://news.medxy.ai/clinical-factors-associated-with-discordant-plasma-p-tau217-and-established-alzheimer-disease-biomarkers-implications-for-diagnosis-and-management/Medxy AIen2026-10-07T06:56:40-07:00Clinical Factors Associated With Discordant Plasma P-Tau217 and Established Alzheimer Disease Biomarkers: Implications for Diagnosis and Management https://news.medxy.ai/zh/us-spinal-injury-trends/Medxy AIzh2026-10-07T06:55:35-07:00美国创伤性脊髓损伤死亡趋势（1999—2024）：人口学差异与大流行影响的启示 https://news.medxy.ai/ja/81563-2/Medxy AIja2026-10-07T06:55:17-07:00米国における脊髄損傷による死亡（1999～2024年）：傾向、人口統計学的格差、およびパンデミックの影響 https://news.medxy.ai/vi/spinal-cord-injury-deaths/Medxy AIvi2026-10-07T06:54:56-07:00Tử vong do chấn thương tủy sống tại Hoa Kỳ (1999–2024): Xu hướng, chênh lệch nhân khẩu học và tác động của đại dịch https://news.medxy.ai/traumatic-spinal-cord-injury-mortality-trends-in-the-u-s-1999-2024-insights-into-demographic-disparities-and-pandemic-impact/Medxy AIen2026-10-07T06:54:39-07:00Traumatic Spinal Cord Injury Mortality Trends in the U.S. (1999-2024): Insights into Demographic Disparities and Pandemic Impact https://news.medxy.ai/zh/type-2-diabetes-body-change/Medxy AIzh2026-10-07T06:53:53-07:002型糖尿病诊断前后体成分如何变化？来自欧洲与美国三大队列的纵向证据 https://news.medxy.ai/ja/type-2-diabetes-bodycomposition/Medxy AIja2026-10-07T06:53:37-07:002型糖尿病診断前後の体組成はどう変化するのか：欧州・米国3コホートから見えた動態 https://news.medxy.ai/vi/body-composition-changes/Medxy AIvi2026-10-07T06:53:18-07:00Diễn biến động của thành phần cơ thể quanh thời điểm chẩn đoán đái tháo đường típ 2: Bằng chứng từ ba đoàn hệ châu Âu và Hoa Kỳ https://news.medxy.ai/dynamic-patterns-of-body-composition-remodeling-around-type-2-diabetes-diagnosis-insights-from-three-european-and-us-cohorts/Medxy AIen2026-10-07T06:53:01-07:00Dynamic Patterns of Body Composition Remodeling Around Type 2 Diabetes Diagnosis: Insights from Three European and US Cohorts https://news.medxy.ai/ja/diabetic-foot-ulcer-treatment/Medxy AIja2026-10-07T06:52:15-07:00糖尿病関連足潰瘍のオフローディング治療はどれが環境にやさしいか：ライフサイクルアセスメント https://news.medxy.ai/vi/environmental-sustainability-diabetic-foot/Medxy AIvi2026-10-07T06:51:52-07:00Tính bền vững môi trường của các lộ trình giảm tải trong chăm sóc loét bàn chân do đái tháo đường: Phân tích vòng đời https://news.medxy.ai/environmental-sustainability-of-offloading-care-pathways-for-people-with-diabetes-related-foot-ulcers-a-life-cycle-assessment/Medxy AIen2026-10-07T06:51:32-07:00Environmental Sustainability of Offloading Care Pathways for People with Diabetes-Related Foot Ulcers: A Life-Cycle Assessment https://news.medxy.ai/zh/prolactinoma-management/Medxy AIzh2026-10-07T06:50:51-07:00妊娠期泌乳素瘤管理：以证据为基础，兼顾母胎最佳结局 https://news.medxy.ai/ja/prolactinoma-pregnancy-management/Medxy AIja2026-10-07T06:50:32-07:00妊娠中のプロラクチノーマをどう管理するか：母児の良好な転帰を目指すエビデンスに基づく実践 https://news.medxy.ai/vi/prolactinoma-pregnancy-management-2/Medxy AIvi2026-10-07T06:49:47-07:00Quản lý prolactinoma trong thai kỳ: Tiếp cận dựa trên bằng chứng để tối ưu kết cục cho mẹ và thai nhi https://news.medxy.ai/navigating-prolactinomas-in-pregnancy-an-evidence-based-approach-for-optimal-maternal-and-fetal-outcomes/Medxy AIen2026-10-07T06:49:26-07:00Navigating Prolactinomas in Pregnancy: An Evidence-Based Approach for Optimal Maternal and Fetal Outcomes https://news.medxy.ai/ja/hypothalamic-amenorrhea-risk/Medxy AIja2026-10-07T06:48:35-07:00機能性視床下部性無月経の表現型と心血管疾患リスク https://news.medxy.ai/vi/hypogonadism-cvd-risk/Medxy AIvi2026-10-07T06:48:16-07:00Vô kinh vùng dưới đồi chức năng và nguy cơ bệnh tim mạch: Kiểu hình cần được nhận diện sớm https://news.medxy.ai/functional-hypothalamic-amenorrhea-phenotype-and-cardiovascular-disease-risk/Medxy AIen2026-10-07T06:47:59-07:00Functional Hypothalamic Amenorrhea Phenotype and Cardiovascular Disease Risk https://news.medxy.ai/zh/maternal-protection-type-1-diabetes/Medxy AIzh2026-10-07T06:47:23-07:00揭示母体对1型糖尿病的保护作用：遗传风险与宫内影响 https://news.medxy.ai/ja/81540-2/Medxy AIja2026-10-07T06:47:07-07:001型糖尿病に対する母体由来の保護作用の解明：遺伝的リスクと子宮内環境の影響 https://news.medxy.ai/vi/type-1-diabetes-risk-2/Medxy AIvi2026-10-07T06:46:48-07:00Vì sao con của mẹ mắc đái tháo đường týp 1 có nguy cơ thấp hơn? Vai trò của di truyền và môi trường trong tử cung https://news.medxy.ai/unraveling-maternal-protection-against-type-1-diabetes-genetic-risk-and-intrauterine-influences/Medxy AIen2026-10-07T06:46:31-07:00Unraveling Maternal Protection Against Type 1 Diabetes: Genetic Risk and Intrauterine Influences https://news.medxy.ai/zh/syndecan4-piezo1-thrombosis/Medxy AIzh2026-10-07T06:45:45-07:00揭示 Syndecan-4 与 Piezo1 在深静脉血栓形成中的机制作用：槲皮素带来的治疗启示 https://news.medxy.ai/ja/81535-2/Medxy AIja2026-10-07T06:45:23-07:00深部静脈血栓症におけるSyndecan-4およびPiezo1の役割とメカニズムの解明：ケルセチンによる治療への示唆 https://news.medxy.ai/vi/syndecan4-piezo1-thrombosis-2/Medxy AIvi2026-10-07T06:44:59-07:00Giải mã vai trò cơ chế của Syndecan-4 và Piezo1 trong huyết khối tĩnh mạch sâu: Gợi ý điều trị từ Quercetin https://news.medxy.ai/unraveling-the-mechanistic-role-of-syndecan-4-and-piezo1-in-deep-vein-thrombosis-therapeutic-insights-from-quercetin/Medxy AIen2026-10-07T06:44:35-07:00Unraveling the Mechanistic Role of Syndecan-4 and Piezo1 in Deep Vein Thrombosis: Therapeutic Insights from Quercetin https://news.medxy.ai/zh/adult-congenital-heart-disease/Medxy AIzh2026-10-07T06:43:41-07:00成人先天性心脏病：在不断演变的医疗格局中实现终身管理 https://news.medxy.ai/ja/81530-2/Medxy AIja2026-10-07T06:43:13-07:00成人先天性心疾患：絶えず変化する医療環境下での生涯にわたる管理の実現 https://news.medxy.ai/vi/adult-congenital-heart-disease-2/Medxy AIvi2026-10-07T06:42:31-07:00Bệnh tim bẩm sinh ở người trưởng thành: Hành trình chăm sóc suốt đời trong bối cảnh y tế không ngừng đổi thay https://news.medxy.ai/adult-congenital-heart-disease-navigating-lifelong-care-in-an-evolving-health-landscape/Medxy AIen2026-10-07T06:42:12-07:00Adult Congenital Heart Disease: Navigating Lifelong Care in an Evolving Health Landscape https://news.medxy.ai/ja/left-main-pci-imaging-2/Medxy AIja2026-10-07T06:41:30-07:00左主幹部PCIにおける血管内イメージング：2026年EAPCI–EBC臨床コンセンサスの要点 https://news.medxy.ai/vi/imaging-for-left-main-pci/Medxy AIvi2026-10-07T06:40:59-07:00Chẩn đoán hình ảnh trong lòng mạch cho PCI thân chung trái: các khuyến nghị then chốt từ đồng thuận lâm sàng EAPCI–EBC 2026 https://news.medxy.ai/zh/pci-imaging-consensus/Medxy AIzh2026-10-07T06:40:25-07:00左主干 PCI 的冠内影像应用：2026 年 EAPCI–EBC 临床共识核心要点 https://news.medxy.ai/left-main-pci-imaging/Medxy AIen2026-10-07T06:39:54-07:00Intracoronary imaging for left main PCI: key recommendations from the 2026 EAPCI–EBC clinical consensus https://news.medxy.ai/zh/type-2-diabetes-management-4/Medxy AIzh2026-10-07T06:31:50-07:002型糖尿病血糖管理再升级：数字疗法 Glucura 联合 CGM，6 个月疗效更优 https://news.medxy.ai/ja/type-2-diabetes-management-3/Medxy AIja2026-10-07T06:31:32-07:002型糖尿病の血糖管理をさらに高める：デジタル治療 glucura と CGM の併用で6か月成績が大きく改善 https://news.medxy.ai/vi/81507-2/Medxy AIvi2026-10-07T06:31:10-07:00Nâng cao hiệu quả kiểm soát đường huyết ở bệnh nhân đái tháo đường tuýp 2: Kết quả cải thiện đáng kể sau 6 tháng khi kết hợp liệu pháp kỹ thuật số Glucura và CGM https://news.medxy.ai/enhanced-glycaemic-control-in-type-2-diabetes-digital-therapeutic-glucura-combined-with-cgm-shows-superior-6-month-outcomes/Medxy AIen2026-10-07T06:30:44-07:00Enhanced Glycaemic Control in Type 2 Diabetes: Digital Therapeutic Glucura Combined with CGM Shows Superior 6-Month Outcomes https://news.medxy.ai/zh/81504-2/Medxy AIzh2026-10-07T06:29:55-07:00肝脏来源的ApoJ破坏脂质稳态并加重糖尿病性肾损伤 https://news.medxy.ai/ja/apoj-lipid-disorder/Medxy AIja2026-10-07T06:29:36-07:00肝由来ApoJが脂質恒常性を乱し糖尿病性腎障害を悪化させる https://news.medxy.ai/vi/81502-2/Medxy AIvi2026-10-07T06:29:14-07:00ApoJ có nguồn gốc từ gan làm rối loạn cân bằng nội môi lipid và làm trầm trọng thêm bệnh thận do đái tháo đường https://news.medxy.ai/liver-derived-apolipoprotein-j-drives-diabetic-kidney-injury-by-disrupting-lipid-homeostasis/Medxy AIen2026-10-07T06:28:50-07:00Liver-Derived Apolipoprotein J Drives Diabetic Kidney Injury by Disrupting Lipid Homeostasis https://news.medxy.ai/zh/81499-2/Medxy AIzh2026-10-07T06:28:07-07:00急性NAION视神经乳头水肿速度可预测视功能预后恶化 https://news.medxy.ai/ja/naion-optic-disc-swelling/Medxy AIja2026-10-07T06:27:43-07:00急性NAIONの視神経乳頭腫脹速度は視機能予後の悪化を予測する：エビデンスレビュー https://news.medxy.ai/vi/81497-2/Medxy AIvi2026-10-07T06:27:17-07:00Tốc độ phù gai thị trong bệnh NAION cấp tính dự báo sự xấu đi của tiên lượng chức năng thị giác: Đánh giá bằng chứng https://news.medxy.ai/early-optic-nerve-head-swelling-rate-predicts-visual-outcome-deterioration-in-nonarteritic-anterior-ischemic-optic-neuropathy-an-evidence-based-review/Medxy AIen2026-10-07T06:26:52-07:00Early Optic Nerve Head Swelling Rate Predicts Visual Outcome Deterioration in Nonarteritic Anterior Ischemic Optic Neuropathy: An Evidence-Based Review https://news.medxy.ai/zh/placenta-penetration-removal/Medxy AIzh2026-10-07T06:03:08-07:00基于病理解剖学的胎盘穿透性植入局灶切除：应对新生血管化难题的保宫策略 https://news.medxy.ai/ja/81583-2/Medxy AIja2026-10-07T06:02:49-07:00病理解剖学的知見に基づく胎盤穿通性癒着胎盤の局所切除：新生血管形成という難題に対処する子宮温存戦略 https://news.medxy.ai/vi/81582-2/Medxy AIvi2026-10-07T06:02:28-07:00Cắt bỏ khu trú nhau cài răng lược xuyên cơ dựa trên giải phẫu bệnh: Chiến lược bảo tồn tử cung nhằm giải quyết thách thức về sự tân tạo mạch máu https://news.medxy.ai/zh/hifu-twin-twin-transfusion/Medxy AIzh2026-10-07T06:01:27-07:00超声引导高强度聚焦超声：早发型双胎输血综合征胎盘血管闭塞的新选择 https://news.medxy.ai/ja/early-twin-transfusion-treatment/Medxy AIja2026-10-07T06:01:09-07:00早発性双胎間輸血症候群に対する超音波ガイド下高強度集束超音波――胎盤血管を安全に閉塞しうる新規治療の検討 https://news.medxy.ai/vi/hifu-placental-blood-flow/Medxy AIvi2026-10-07T06:00:48-07:00Khám phá HIFU có hướng dẫn bằng siêu âm trong bít tắc an toàn các mạch máu nhau thai ở hội chứng truyền máu song thai khởi phát sớm https://news.medxy.ai/zh/81153-2/Medxy AIzh2026-10-06T07:08:11-07:00影响NAION视功能恶化的早期视神经乳头水肿速度：基于循证医学的综述 https://news.medxy.ai/ja/naion-optic-nerve-swelling/Medxy AIja2026-10-06T07:07:48-07:00NAIONの視機能悪化を左右する早期視神経乳頭腫脹速度：エビデンスに基づく総説 https://news.medxy.ai/vi/optic-nerve-conduction-speed/Medxy AIvi2026-10-06T07:07:22-07:00Tốc độ phù đầu dây thần kinh thị giác sớm liên quan với suy giảm thị lực trong bệnh lý thần kinh thị giác thiếu máu cục bộ trước không do động mạch: Tổng quan dựa trên bằng chứng https://news.medxy.ai/early-optic-nerve-head-swelling-rate-correlates-with-visual-decline-in-nonarteritic-anterior-ischemic-optic-neuropathy-an-evidence-based-review/Medxy AIen2026-10-06T07:06:59-07:00Early Optic Nerve Head Swelling Rate Correlates with Visual Decline in Nonarteritic Anterior Ischemic Optic Neuropathy: An Evidence-Based Review https://news.medxy.ai/zh/cetp-inhibition-benefits-risks/Medxy AIzh2026-10-06T07:06:13-07:00CETP抑制：心血管获益与年龄相关性黄斑变性风险之间的“双刃剑” https://news.medxy.ai/ja/cetp-inhibition-risk/Medxy AIja2026-10-06T07:05:50-07:00CETP阻害は心血管保護か、網膜リスクか：加齢黄斑変性をめぐる遺伝学的検証 https://news.medxy.ai/vi/cetp-inhibition-tradeoff/Medxy AIvi2026-10-06T07:05:29-07:00Ức chế CETP: “con dao hai lưỡi” giữa lợi ích tim mạch và nguy cơ thoái hóa hoàng điểm do tuổi tác https://news.medxy.ai/cholesteryl-ester-transfer-protein-inhibition-a-double-edged-sword-in-cardiovascular-health-and-age-related-macular-degeneration-risk/Medxy AIen2026-10-06T07:05:08-07:00Cholesteryl Ester Transfer Protein Inhibition: A Double-Edged Sword in Cardiovascular Health and Age-Related Macular Degeneration Risk https://news.medxy.ai/zh/remote-eye-pressure-monitoring-2/Medxy AIzh2026-10-06T07:04:31-07:00远程监测眼压与新型阈值指标，可预测治疗中开角型青光眼的视野进展 https://news.medxy.ai/vi/remote-intraocular-pressure/Medxy AIvi2026-10-06T07:03:50-07:00Theo dõi áp lực nội nhãn từ xa và các chỉ số ngưỡng mới dự đoán tiến triển thị trường ở glaucoma góc mở đã điều trị https://news.medxy.ai/remote-intraocular-pressure-monitoring-and-novel-threshold-metrics-predict-visual-field-progression-in-treated-open-angle-glaucoma/Medxy AIen2026-10-06T07:03:28-07:00Remote Intraocular Pressure Monitoring and Novel Threshold Metrics Predict Visual Field Progression in Treated Open-Angle Glaucoma https://news.medxy.ai/zh/81121-2/Medxy AIzh2026-10-06T07:02:51-07:00头颈部癌放疗后的长期阿片类药物使用：患病率、风险因素及临床意义 https://news.medxy.ai/ja/opioid-use-head-neck-cancer/Medxy AIja2026-10-06T07:02:30-07:00頭頸部癌の放射線治療後に長引くオピオイド使用：有病率・リスク因子・臨床的意義 https://news.medxy.ai/vi/long-term-opioid-use/Medxy AIvi2026-10-06T07:02:07-07:00Sử dụng opioid kéo dài sau xạ trị ở ung thư đầu và cổ: Tỷ lệ hiện mắc, yếu tố nguy cơ và ý nghĩa lâm sàng https://news.medxy.ai/long-term-opioid-use-after-radiation-therapy-in-head-and-neck-cancer-prevalence-risk-factors-and-clinical-implications/Medxy AIen2026-10-06T07:01:46-07:00Long-Term Opioid Use After Radiation Therapy in Head and Neck Cancer: Prevalence, Risk Factors, and Clinical Implications https://news.medxy.ai/zh/testosterone-suppression-cancer-risk/Medxy AIzh2026-10-06T07:01:12-07:00抑制睾酮或可降低男性喉癌与下咽癌风险：来自瑞典大型队列的研究发现 https://news.medxy.ai/ja/81111-2/Medxy AIja2026-10-06T07:00:54-07:00テストステロンの抑制が男性の喉頭がん・下咽頭がんのリスクを低減させる可能性 https://news.medxy.ai/vi/testosterone-inhibition-cancer-risk/Medxy AIvi2026-10-06T07:00:34-07:00Ức chế testosterone có liên quan đến giảm nguy cơ ung thư biểu mô tế bào vảy thanh quản và hạ họng ở nam giới: Góc nhìn từ một đoàn hệ lớn tại Thụy Điển https://news.medxy.ai/testosterone-inhibition-and-reduced-risk-of-laryngeal-and-hypopharyngeal-squamous-cell-carcinoma-in-men-insights-from-a-large-swedish-cohort/Medxy AIen2026-10-06T07:00:14-07:00Testosterone Inhibition and Reduced Risk of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma in Men: Insights from a Large Swedish Cohort https://news.medxy.ai/zh/salivary-gland-tumor-diagnosis/Medxy AIzh2026-10-06T06:59:38-07:00大唾液腺肿瘤诊断的新进展：粗针穿刺活检的临床价值 https://news.medxy.ai/ja/81099-2/Medxy AIja2026-10-06T06:59:19-07:00大唾液腺腫瘍診断の新たな進展：太い針による穿刺生検の臨床的意義 https://news.medxy.ai/vi/salivary-gland-biopsy/Medxy AIvi2026-10-06T06:59:00-07:00Nâng cao chẩn đoán u tuyến nước bọt lớn: Giá trị lâm sàng của sinh thiết kim lõi https://news.medxy.ai/advancing-diagnosis-of-major-salivary-gland-tumors-the-clinical-value-of-core-needle-biopsy/Medxy AIen2026-10-06T06:58:39-07:00Advancing Diagnosis of Major Salivary Gland Tumors: The Clinical Value of Core Needle Biopsy https://news.medxy.ai/zh/bone-healing-factors/Medxy AIzh2026-10-06T06:58:06-07:00骨愈合是否关键？骨性微血管中面部重建结局的影响因素分析 https://news.medxy.ai/ja/bone-healing-impact/Medxy AIja2026-10-06T06:57:45-07:00骨癒合は転帰に影響するのか：骨性マイクロバスキュラー中顔面再建における検討 https://news.medxy.ai/vi/bone-healing-impact-2/Medxy AIvi2026-10-06T06:57:23-07:00Đánh giá ảnh hưởng của sự liền xương đối với kết quả tái tạo tầng giữa mặt bằng vạt vi phẫu xương https://news.medxy.ai/evaluating-the-impact-of-bony-union-on-outcomes-in-osseous-microvascular-midface-reconstruction/Medxy AIen2026-10-06T06:57:01-07:00Evaluating the Impact of Bony Union on Outcomes in Osseous Microvascular Midface Reconstruction https://news.medxy.ai/zh/fungal-sinusitis-differentiation/Medxy AIzh2026-10-06T06:56:25-07:00从结构化组织病理学看沙特队列中变应性真菌性鼻-鼻窦炎与嗜酸性粒细胞性伴鼻息肉慢性鼻-鼻窦炎的鉴别 https://news.medxy.ai/ja/eosinophilic-sinusitis/Medxy AIja2026-10-06T06:56:04-07:00アレルギー性真菌性鼻副鼻腔炎と鼻茸を伴う好酸球性慢性鼻副鼻腔炎の鑑別：サウジアラビア・コホートにおける構造化病理組織学からの知見 https://news.medxy.ai/vi/allergic-fungal-vs-eosinophilic-sinusitis/Medxy AIvi2026-10-06T06:55:43-07:00Phân biệt viêm mũi xoang do nấm dị ứng với viêm mũi xoang mạn tính tăng bạch cầu ái toan có polyp mũi: góc nhìn từ mô bệnh học có cấu trúc trên một đoàn hệ Saudi Arabia https://news.medxy.ai/differentiating-allergic-fungal-rhinosinusitis-from-eosinophilic-chronic-rhinosinusitis-with-nasal-polyps-insights-from-structured-histopathology-in-a-saudi-cohort/Medxy AIen2026-10-06T06:55:22-07:00Differentiating Allergic Fungal Rhinosinusitis from Eosinophilic Chronic Rhinosinusitis with Nasal Polyps: Insights from Structured Histopathology in a Saudi Cohort https://news.medxy.ai/ja/appendiceal-abscess-management/Medxy AIja2026-10-06T06:54:46-07:00虫垂膿瘍をどう扱うか――2025年イタリア・コンセンサスが示す実践的フレームワーク https://news.medxy.ai/vi/appendix-abscess-management/Medxy AIvi2026-10-06T06:54:11-07:00Áp-xe ruột thừa: Khung xử trí thực hành dựa trên sinh lý học từ Đồng thuận Ý 2025 https://news.medxy.ai/zh/81074-2/Medxy AIzh2026-10-06T06:53:38-07:00如何处理阑尾脓肿——2025年意大利共识提出的实践框架 https://news.medxy.ai/a-practical-physiology-driven-framework-for-appendiceal-abscess-key-recommendations-from-the-2025-italian-consensus/Medxy AIen2026-10-06T06:53:08-07:00A Practical, Physiology-Driven Framework for Appendiceal Abscess: Key Recommendations from the 2025 Italian Consensus https://news.medxy.ai/zh/frailty-predicts-outcomes/Medxy AIzh2026-10-06T06:52:05-07:00超越年龄：虚弱比实际年龄更能预测老年患者术后结局 https://news.medxy.ai/ja/beyond-age-frailty/Medxy AIja2026-10-06T06:51:47-07:00年齢を超えて：高齢者の術後転帰を最もよく予測するのはフレイル https://news.medxy.ai/vi/age-frailty-surgery/Medxy AIvi2026-10-06T06:51:24-07:00Vượt qua tuổi tác: Suy yếu là yếu tố dự đoán vượt trội về kết cục sau phẫu thuật ở người cao tuổi https://news.medxy.ai/beyond-age-frailty-as-a-superior-predictor-of-postoperative-outcomes-in-older-adults/Medxy AIen2026-10-06T06:51:03-07:00Beyond Age: Frailty as a Superior Predictor of Postoperative Outcomes in Older Adults https://news.medxy.ai/zh/aldo-renin-ratio-threshold/Medxy AIzh2026-10-06T06:50:27-07:00优化醛固酮/肾素比值阈值：提高正常醛固酮水平患者原发性醛固酮增多症的检出率 https://news.medxy.ai/ja/aldosterone-renin-ratio-2/Medxy AIja2026-10-06T06:50:04-07:00原発性アルドステロン症の拾い上げを高める：アルドステロン／レニン比の閾値再検討 https://news.medxy.ai/vi/aldosterone-renin-ratio-3/Medxy AIvi2026-10-06T06:49:39-07:00Hiệu chỉnh ngưỡng tỷ lệ aldosterone trên renin: Nâng cao phát hiện cường aldosterone tiên phát ở bệnh nhân có nồng độ aldosterone bình thường https://news.medxy.ai/refining-aldosterone-to-renin-ratio-thresholds-improving-detection-of-primary-aldosteronism-in-patients-with-normal-aldosterone-levels/Medxy AIen2026-10-06T06:49:14-07:00Refining Aldosterone-to-Renin Ratio Thresholds: Improving Detection of Primary Aldosteronism in Patients with Normal Aldosterone Levels https://news.medxy.ai/zh/racial-disparities-trauma-care/Medxy AIzh2026-10-06T06:48:35-07:00创伤患者院前救治中的种族差异：基于证据的综述 https://news.medxy.ai/ja/racial-disparities-prehospital-care/Medxy AIja2026-10-06T06:48:13-07:00受傷患者の病院前介入における人種差：エビデンスに基づく総説 https://news.medxy.ai/vi/81049-2/Medxy AIvi2026-10-06T06:47:49-07:00Chênh lệch về chủng tộc trong chăm sóc tiền bệnh viện cho bệnh nhân chấn thương: Tổng quan dựa trên bằng chứng https://news.medxy.ai/racial-disparities-in-prehospital-interventions-among-injured-patients-an-evidence-based-review/Medxy AIen2026-10-06T06:47:27-07:00Racial Disparities in Prehospital Interventions Among Injured Patients: An Evidence-Based Review https://news.medxy.ai/zh/81039-2/Medxy AIzh2026-10-06T06:46:32-07:00良性及低级别胰头肿瘤：肿瘤剜除术与胰十二指肠切除术的当代证据综合分析 https://news.medxy.ai/ja/benign-pancreatic-tumor-surgery/Medxy AIja2026-10-06T06:46:05-07:00良性・低悪性度膵頭部腫瘍に対する核出術と膵頭十二指腸切除術：最新エビデンスの総括 https://news.medxy.ai/vi/tumor-removal-options/Medxy AIvi2026-10-06T06:45:41-07:00Bóc nhân khối u hay cắt tá tràng – tụy: lựa chọn nào tối ưu cho khối u lành tính và độ thấp ở đầu tụy? https://news.medxy.ai/enucleation-vs-pancreatoduodenectomy-for-benign-and-low-grade-pancreatic-head-tumors-a-contemporary-evidence-synthesis/Medxy AIen2026-10-06T06:45:15-07:00Enucleation vs Pancreatoduodenectomy for Benign and Low-Grade Pancreatic Head Tumors: A Contemporary Evidence Synthesis https://news.medxy.ai/zh/robot-assisted-vs-thoracoscopic/Medxy AIzh2026-10-06T06:44:26-07:00机器人辅助还是胸腹腔镜？食管癌手术精准度的进一步提升 https://news.medxy.ai/ja/robotic-surgery-advances/Medxy AIja2026-10-06T06:44:06-07:00ロボット手術は胸腹腔鏡手術を上回るか？　食道癌治療における精密外科の新展開 https://news.medxy.ai/vi/robotic-esophagectomy/Medxy AIvi2026-10-06T06:43:41-07:00Phẫu thuật cắt thực quản bằng robot hay thoracolaparoscopic: Nâng cao độ chính xác trong điều trị ung thư thực quản https://news.medxy.ai/robotic-vs-thoracolaparoscopic-esophagectomy-advancing-surgical-precision-in-esophageal-cancer-treatment/Medxy AIen2026-10-06T06:43:19-07:00Robotic vs Thoracolaparoscopic Esophagectomy: Advancing Surgical Precision in Esophageal Cancer Treatment https://news.medxy.ai/zh/medicaid-expansion-survival/Medxy AIzh2026-10-06T06:42:39-07:00Medicaid扩展对结直肠癌肝转移患者生存的影响：基于人群的分析 https://news.medxy.ai/ja/81014-2/Medxy AIja2026-10-06T06:42:21-07:00メディケイドの拡大が結腸直腸癌の肝転移患者の生存に及ぼす影響 https://news.medxy.ai/vi/81013-2/Medxy AIvi2026-10-06T06:41:58-07:00Tác động của việc mở rộng Medicaid đến tỷ lệ sống còn ở bệnh nhân ung thư đại trực tràng di căn gan https://news.medxy.ai/impact-of-medicaid-expansion-on-survival-in-colorectal-cancer-with-liver-metastasis-a-population-based-analysis/Medxy AIen2026-10-06T06:41:35-07:00Impact of Medicaid Expansion on Survival in Colorectal Cancer with Liver Metastasis: A Population-Based Analysis https://news.medxy.ai/zh/81006-2/Medxy AIzh2026-10-06T06:40:58-07:00针对肝细胞癌的肝移植：完全病理学缓解对预后的影响及治疗方案的差异——基于美国全国数据库的研究 https://news.medxy.ai/ja/liver-transplant-outcomes/Medxy AIja2026-10-06T06:40:34-07:00肝細胞癌に対する肝移植：完全病理学的奏効の予後への影響と治療法の差異―米国全国データベース研究 https://news.medxy.ai/vi/81000-2/Medxy AIvi2026-10-06T06:40:07-07:00Ghép gan điều trị ung thư biểu mô tế bào gan: Ảnh hưởng của đáp ứng bệnh học hoàn toàn đến tiên lượng và sự khác biệt về phương pháp điều trị – Nghiên cứu dựa trên cơ sở dữ liệu toàn quốc của Hoa Kỳ https://news.medxy.ai/liver-transplantation-hcc/Medxy AIen2026-10-06T06:39:42-07:00Liver Transplantation for Hepatocellular Carcinoma: Prognostic Impact of Complete Pathologic Response and Influence of Treatment Modality—A US National Database Study https://news.medxy.ai/zh/robot-assisted-esophagectomy/Medxy AIzh2026-10-06T06:38:48-07:00机器人辅助食管切除术：重塑食管癌外科治疗的新标杆 https://news.medxy.ai/ja/robotic-esophagectomy-guide/Medxy AIja2026-10-06T06:38:31-07:00食道癌手術の新たな指標を築くロボット支援食道切除術 https://news.medxy.ai/vi/robot-assisted-esophagectomy-2/Medxy AIvi2026-10-06T06:38:11-07:00Cắt thực quản hỗ trợ robot: Nâng tầm chuẩn mực phẫu thuật trong chăm sóc ung thư thực quản https://news.medxy.ai/robotic-assisted-esophagectomy-transforming-surgical-benchmarks-in-esophageal-cancer-care/Medxy AIen2026-10-06T06:37:53-07:00Robotic-Assisted Esophagectomy: Transforming Surgical Benchmarks in Esophageal Cancer Care https://news.medxy.ai/zh/80981-2/Medxy AIzh2026-10-06T06:37:21-07:00评估帕博利珠单抗、贝伐珠单抗联合口服节律性环磷酰胺治疗经多线治疗的铂耐药卵巢癌：真实世界疗效与临床启示 https://news.medxy.ai/ja/platinum-resistant-ovarian-cancer-treatment/Medxy AIja2026-10-06T06:36:58-07:00多治療歴プラチナ抵抗性卵巣癌に対するペムブロリズマブ・ベバシズマブ・経口メトロノミック・シクロホスファミドの評価：実臨床成績と臨床的示唆 https://news.medxy.ai/vi/80975-2/Medxy AIvi2026-10-06T06:36:33-07:00Phối hợp pembrolizumab, bevacizumab và cyclophosphamide đường uống theo phác đồ metronomic cho ung thư buồng trứng kháng platin đã trải qua nhiều đợt điều trị trước đó https://news.medxy.ai/evaluating-pembrolizumab-bevacizumab-and-oral-metronomic-cyclophosphamide-in-heavily-pretreated-platinum-resistant-ovarian-cancer-real-world-outcomes-and-clinical-implications/Medxy AIen2026-10-06T06:36:07-07:00Evaluating Pembrolizumab, Bevacizumab, and Oral Metronomic Cyclophosphamide in Heavily Pretreated Platinum-Resistant Ovarian Cancer: Real-World Outcomes and Clinical Implications https://news.medxy.ai/zh/endometrial-cancer-genetics/Medxy AIzh2026-10-06T06:35:23-07:00子宫内膜癌的遗传学检测：致病性胚系变异的流行率及其对临床实践的启示 https://news.medxy.ai/ja/80962-2/Medxy AIja2026-10-06T06:35:02-07:00子宮内膜癌の遺伝学的検査：病原性生殖細胞系列変異の有病率と臨床診療への示唆 https://news.medxy.ai/vi/80961-2/Medxy AIvi2026-10-06T06:34:42-07:00Xét nghiệm di truyền ung thư nội mạc tử cung: Tỷ lệ biến thể dòng mầm gây bệnh và ý nghĩa đối với thực hành lâm sàng https://news.medxy.ai/genetic-testing-in-endometrial-cancer-prevalence-of-pathogenic-germline-variants-and-implications-for-clinical-practice-in-a-diverse-community-cohort/Medxy AIen2026-10-06T06:34:18-07:00Genetic Testing in Endometrial Cancer: Prevalence of Pathogenic Germline Variants and Implications for Clinical Practice in a Diverse Community Cohort https://news.medxy.ai/zh/elagolix-pain-relief/Medxy AIzh2026-10-06T06:33:44-07:00III期多中心试验证实：elagolix缓解中重度子宫内膜异位症疼痛不劣于dienogest https://news.medxy.ai/ja/elagolix-vs-dienogest/Medxy AIja2026-10-06T06:33:20-07:00中等度〜重度子宮内膜症疼痛に対するElagolixとDienogestの有効性・安全性比較：第III相多施設試験からの知見 https://news.medxy.ai/vi/elagolix-dienogest-comparison/Medxy AIvi2026-10-06T06:32:56-07:00Elagolix hay dienogest: so sánh hiệu quả và độ an toàn trong giảm đau lạc nội mạc tử cung mức độ trung bình đến nặng từ thử nghiệm đa trung tâm giai đoạn III https://news.medxy.ai/comparative-efficacy-and-safety-of-elagolix-versus-dienogest-in-moderate-to-severe-endometriosis-pain-insights-from-a-phase-iii-multicentric-trial/Medxy AIen2026-10-06T06:32:33-07:00Comparative Efficacy and Safety of Elagolix Versus Dienogest in Moderate-to-Severe Endometriosis Pain: Insights from a Phase III Multicentric Trial https://news.medxy.ai/zh/perineal-injury-effects/Medxy AIzh2026-10-06T06:31:54-07:00二度会阴裂伤与会阴切开术后伤口并发症对盆底症状的长期影响：REPAIR研究带来的启示 https://news.medxy.ai/ja/pelvic-floor-symptoms/Medxy AIja2026-10-06T06:31:33-07:00第二度会陰裂傷・会陰切開後の骨盤底症状に対する創傷合併症の長期的影響：REPAIR研究からの知見 https://news.medxy.ai/vi/long-term-wound-effects/Medxy AIvi2026-10-06T06:31:13-07:00Ảnh hưởng lâu dài của biến chứng vết thương đến triệu chứng sàn chậu sau rách tầng sinh môn độ 2 và episiotomy: phát hiện từ nghiên cứu REPAIR https://news.medxy.ai/long-term-impact-of-wound-complications-on-pelvic-floor-symptoms-following-second-degree-tears-and-episiotomy-insights-from-the-repair-study/Medxy AIen2026-10-06T06:30:52-07:00Long-Term Impact of Wound Complications on Pelvic Floor Symptoms Following Second-Degree Tears and Episiotomy: Insights from the REPAIR Study https://news.medxy.ai/zh/obgyn-ai-competency/Medxy AIzh2026-10-06T06:30:14-07:00妇产科临床AI胜任力：在创新与患者安全、责任之间寻求平衡 https://news.medxy.ai/ja/obgyn-ai-competence/Medxy AIja2026-10-06T06:29:58-07:00産科・婦人科における臨床AIコンピテンス：革新と患者安全・説明責任の両立 https://news.medxy.ai/vi/ai-clinical-capacity/Medxy AIvi2026-10-06T06:29:38-07:00Năng lực lâm sàng về AI trong sản khoa và phụ khoa: Cân bằng giữa đổi mới, an toàn người bệnh và trách nhiệm giải trình https://news.medxy.ai/clinical-ai-competence-in-obstetrics-and-gynecology-balancing-innovation-with-patient-safety-and-accountability/Medxy AIen2026-10-06T06:29:19-07:00Clinical AI Competence in Obstetrics and Gynecology: Balancing Innovation with Patient Safety and Accountability https://news.medxy.ai/zh/early-adult-granulosa-tumor/Medxy AIzh2026-10-06T06:28:43-07:00早期成人颗粒细胞瘤的保留卵巢手术：生存结局不劣于双侧卵巢切除术 https://news.medxy.ai/ja/early-adult-granulosa-cell-tumor/Medxy AIja2026-10-06T06:28:21-07:00早期成人型顆粒膜細胞腫に対する卵巣温存手術：両側卵巣摘出術に匹敵する生存成績 https://news.medxy.ai/vi/ovarian-conservation-surgery/Medxy AIvi2026-10-06T06:28:00-07:00Phẫu thuật bảo tồn buồng trứng ở u tế bào hạt trưởng thành giai đoạn sớm: Kết cục sống còn tương đương cắt buồng trứng hai bên https://news.medxy.ai/ovarian-sparing-surgery-in-early-stage-adult-granulosa-cell-tumors-comparable-survival-outcomes-to-bilateral-oophorectomy/Medxy AIen2026-10-06T06:27:39-07:00Ovarian-Sparing Surgery in Early-Stage Adult Granulosa Cell Tumors: Comparable Survival Outcomes to Bilateral Oophorectomy https://news.medxy.ai/zh/carrier-screening-insights/Medxy AIzh2026-10-06T06:26:59-07:00优化携带者筛查：来自母胎医学实践的洞见与建议 https://news.medxy.ai/ja/80913-2/Medxy AIja2026-10-06T06:26:39-07:00保因者スクリーニングの最適化：母体胎児医学の実践から得られる知見と提言 https://news.medxy.ai/vi/80911-2/Medxy AIvi2026-10-06T06:26:19-07:00Tối ưu hóa Sàng lọc Người mang gen bệnh: Những hiểu biết và khuyến nghị từ thực tiễn Y học Bà mẹ – Thai nhi https://news.medxy.ai/optimizing-carrier-screening-insights-and-recommendations-from-a-maternal-fetal-medicine-practice/Medxy AIen2026-10-06T06:25:58-07:00Optimizing Carrier Screening: Insights and Recommendations From a Maternal-Fetal Medicine Practice https://news.medxy.ai/zh/lichen-sclerosus-treatment/Medxy AIzh2026-10-06T06:25:20-07:00外阴硬化性苔藓治疗新进展：CO2 激光与外用丙酸氯倍他索的疗效比较 https://news.medxy.ai/ja/vulvar-lichen-sclerosus-treatment/Medxy AIja2026-10-06T06:24:59-07:00外陰部硬化性苔癬に対するCO2レーザーと外用クロベタゾールの比較：症状管理を変える新知見 https://news.medxy.ai/vi/co2-laser-vs-clobetasol/Medxy AIvi2026-10-06T06:24:40-07:00So sánh liệu pháp laser CO2 với clobetasol bôi trong lichen sclerosus âm hộ: Bước tiến mới trong kiểm soát triệu chứng https://news.medxy.ai/comparing-co2-laser-therapy-and-topical-clobetasol-in-vulvar-lichen-sclerosus-breakthroughs-in-symptom-management/Medxy AIen2026-10-06T06:24:19-07:00Comparing CO2 Laser Therapy and Topical Clobetasol in Vulvar Lichen Sclerosus: Breakthroughs in Symptom Management https://news.medxy.ai/patient-specific-pessaries-after-suboptimal-outcomes-with-standard-pessary-use-a-multicenter-retrospective-case-series/Medxy AIen2026-10-06T06:23:45-07:00Patient-Specific Pessaries After Suboptimal Outcomes With Standard Pessary Use: A Multicenter Retrospective Case Series https://news.medxy.ai/zh/tesera-liver-cancer/Medxy AIzh2026-10-06T06:23:10-07:00TESERA：基于 H&E 全视野切片推动肝细胞癌形态学分型与预后分层 https://news.medxy.ai/ja/heslides-hepatocellular-carcinoma-subtypes/Medxy AIja2026-10-06T06:22:49-07:00H&E全スライド画像から肝細胞癌の形態学的サブタイプと予後を読み解くTESERA https://news.medxy.ai/tesera-advancing-morphologic-subtyping-and-prognostic-stratification-in-hepatocellular-carcinoma-using-he-whole-slide-images/Medxy AIen2026-10-06T06:22:01-07:00TESERA: Advancing Morphologic Subtyping and Prognostic Stratification in Hepatocellular Carcinoma Using H&E Whole-Slide Images https://news.medxy.ai/exceptional-and-durable-response-to-selpercatinib-in-a-patient-with-apparently-ret-negative-hras-and-nf1-mutated-metastatic-medullary-thyroid-carcinoma/Medxy AIen2026-10-06T06:03:01-07:00Exceptional and Durable Response to Selpercatinib in a Patient with Apparently RET-Negative, HRAS-, and NF1-Mutated Metastatic Medullary Thyroid Carcinoma